Voyager Therapeutics and Novartis Sign Deal for Neurological Disease Treatments
Voyager Therapeutics Inc. and Novartis AG signed a licensing agreement to develop treatments for neurological diseases. Shares of Voyager rose after the deal's announcement.
( 1
min )